Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,800
- Value
- $440.6K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,800 | $440.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,800 | $304.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,800 | $328.8K | <0.1% | −67−3.6% | Reduced | Holders |
| Q3 2025 | 1,867 | $226.7K | <0.1% | +1,867 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −1,867−100.0% | Sold out | Holders |
| Q1 2025 | 1,867 | $217.7K | <0.1% | +1,867 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −5,817−100.0% | Sold out | Holders |
| Q1 2024 | 5,817 | $464.2K | <0.1% | +2,000+52.4% | Added | Holders |
| Q4 2023 | 3,817 | $303.8K | <0.1% | +3,817 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −14,200−100.0% | Sold out | Holders |
| Q4 2022 | 14,200 | $1.09M | <0.1% | +14,200 | New | Holders |